- In June 2022, Michelin unveiled the MICHELIN AirProne at the Intensive Care Show 2022, a groundbreaking air cushion system designed for patients with acute respiratory distress syndrome (ARDS). This innovative product aims to improve patient care by promoting optimal positioning and comfort for ARDS patients. The MICHELIN AirProne is designed to enhance ventilation and reduce the risk of complications, offering a novel solution for intensive care settings
- In January 2021, Smith & Nephew Plc acquired Osiris Therapeutics, a company specializing in regenerative medicine and the production of skin and bone substitutes. This acquisition strengthens Smith & Nephew's portfolio in advanced wound care and regenerative therapies. By integrating Osiris Therapeutics’ innovative technologies, Smith & Nephew aims to expand its capabilities in offering cutting-edge solutions for wound healing and tissue regeneration
- In April 2020, AxioBiosolutions launched MaxioCel, an advanced wound care dressing made from chitosan, designed for the treatment of pressure ulcers. This innovative product offers comprehensive care, with benefits including pain management, hemostatic properties, and improved scar healing. MaxioCel aims to enhance wound healing by providing effective, multi-dimensional support for patients with pressure ulcers
- In June 2020, MBET Health introduced the Miracle Dressing Wound Care System (MDS), a proactive solution designed to address the surge in pressure injuries, such as pressure ulcers, resulting from COVID-19 lockdowns and prolonged confinement. This innovative dressing is the first of its kind to provide a 21-day stay-in-place treatment, preventing the formation of pressure sores. The MDS system offers extended care and protection, particularly for individuals facing extended immobility during the pandemic
- In March 2020, Smith+Nephew launched the PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT) in the U.S., featuring an extended pump duration of up to 14 days. This new model improves upon previous generations of PICO sNPWT products, offering enhanced functionality with a pump that requires less user intervention. The PICO 14 system aims to provide more efficient wound care, ensuring better ease of use and improved patient outcomes
Frequently Asked Questions
The market is segmented based on Segmentation, By Treatment (Wound Care Dressings, Wound Care Devices, Active Therapies, and Others), Diagnosis (Blood Tests and Others), Ulcer Type (Stage-1 , Stage-2, Stage-3, Stage-4, and Deep Tissue Injury), End-Users (Clinic, Hospital, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2031
.
The Global Pressure Ulcer Treatment Market size was valued at USD 9.08 USD Billion in 2023.
The Global Pressure Ulcer Treatment Market is projected to grow at a CAGR of 6.3% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
